JP Morgan Chase
IDXX icon

JP Morgan Chase’s Idexx Laboratories IDXX Stock Holding History

JP Morgan Chase’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-25,000
Closed -$1.96M – 4865
2016
Q1 		$1.96M Buy
+25,000
New +$1.8M ﹤0.01% 2714

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

JP Morgan Chase's IDXX Position: Q2 2026 in Review

JP Morgan Chase reduced its Idexx Laboratories (IDXX) stake by 3.1% in Q2 2026, selling an estimated $13.5M and leaving 755,791 shares worth $405M. The position accounts for 0.02% of the portfolio, ranked #515.

JP Morgan Chase first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $556M in Q3 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • JP Morgan Chase held 755,791 shares of Idexx Laboratories worth $405M as of Q2 2026.
  • JP Morgan Chase sold 24,091 Idexx Laboratories shares in Q2 2026, an estimated $13.5M.
  • Idexx Laboratories made up 0.02% of JP Morgan Chase's portfolio in Q2 2026, its #515 holding.
  • JP Morgan Chase first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Idexx Laboratories position peaked at $556M in Q3 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.